Researchers explain that these insights have important implications, if validated in further research, as challenges with early detection of dilated cardiomyopathy complicate myasthenia gravis ...
To combat viruses, bacteria and other pathogens, synthetic biology offers new technological approaches whose performance is being validated in experiments. Researchers applied data integration and ...
Antimicrobial resistance (AMR) is diminishing the effectiveness of existing antibiotics and intensifying the need for discovery pipelines that are both ...
BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Alloy Therapeutics, a biotechnology ecosystem company, announced it has acquired deepCDR Biologics, a Basel, Switzerland-based developer of deep learning ...
Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.
This seminar series is developed and sponsored by the UAB Department of Biomedical Informatics and Data Science (DBIDS). It educates individuals on research innovations in biomedical informatics. The ...
Rectal cancer in young patients: Clinicoepidemiologic profile and treatment outcomes. TAS-116, an oral HSP90 inhibitor, in combination with nivolumab in patients with colorectal cancer and other solid ...
Yuval Kluger, who works in the broad fields of bioinformatics, machine learning, and applied mathematics to develop new approaches for analyzing large biological data sets, was recently appointed the ...
In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
Bioinformaticians have been utilizing machine learning for years. However, the introduction of powerful and easily accessible generative AI tools is a new horizon. Learning how to use these tools to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results